Iovance Biotherapeutics (2LB.F) Q4 2021 Earnings

23FebExpected
Q1 2021
Aug 21
Q3 2021
Q4 2021
-0.53
-0.52
-0.52
-0.51

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Iovance Biotherapeutics (2LB.F) will report earnings of for Q4 2021 on February 23, 2022.

0 Comments

Share your thoughts